Azasan and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azasan (azathioprine) and Methotrexate (methotrexate sodium). Common drug interactions include cardiac flutter among females and drug eruption among males.

The phase IV clinical study analyzes what interactions people have when they take Azasan and Methotrexate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Azasan?

Azasan has active ingredients of azathioprine. eHealthMe is studying from 413 Azasan users. Check the latest studies of Azasan.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,314 Methotrexate users. Check the latest studies of Methotrexate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

12 people who take Azasan and Methotrexate together, and have interactions are studied.

Azasan and Methotrexate drug interactions.

What are the common drug interactions of Azasan and Methotrexate, by gender? *:

female:

  1. Cardiac flutter (abnormal heart rhythm)
  2. Diarrhoea
  3. Heart rate increased
  4. Infusion site rash
  5. Erythema (redness of the skin)
  6. Infusion site warmth
  7. Dyslipidaemia (abnormal amount of lipids)
  8. Feeling hot
  9. Infusion site erythema (reddening of the skin at infusion site)
  10. Muscle tightness

male:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Drug ineffective
  3. Epistaxis (bleed from the nose)
  4. Hypersensitivity
  5. Muscle spasms (muscle contraction)
  6. Pain in extremity
  7. Pneumonia
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the common drug interactions of Azasan and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac flutter (abnormal heart rhythm)
  2. Diarrhoea
  3. Headache (pain in head)
  4. Heart rate increased
  5. Infusion site rash
  6. Erythema (redness of the skin)
  7. Infusion site warmth
  8. Feeling hot
  9. Infusion site erythema (reddening of the skin at infusion site)
  10. Muscle tightness

40-49:

n/a

50-59:

  1. Oral pain
  2. Arthropathy
  3. Drug ineffective
  4. Dry mouth
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)

60+:

  1. Dyslipidaemia (abnormal amount of lipids)
  2. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  3. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  4. Breast cancer

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 41.67%
  2. Uveitis (inflammation of the uvea): 1 person, 8.33%
  3. Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
  4. High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azasan and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azasan and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azasan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azasan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azathioprine and methotrexate sodium (the active ingredients of Azasan and Methotrexate, respectively), and Azasan and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: